J. 2016;10:19-27. \[[PMC free article: PMC4780514](/pmc/articles/PMC4780514/)\] \[[PubMed: 27014374](https://pubmed.ncbi.nlm.nih.gov/27014374)\] 2. Luks AM, Swenson ER, Bärtsch P. Acute high-altitude sickness. Eur Respir Rev. 2017 Jan;26(143) \[[PMC free article: PMC9488514](/pmc/articles/PMC9488514/)\] \[[PubMed: 28143879](https://pubmed.ncbi.nlm.nih.gov/28143879)\] 3. Aksel G, Çorbacıoğlu ŞK, Özen C. High-altitude illness: Management approach. Turk J Emerg Med. 2019 Oct;19(4):121-126. \[[PMC free article: PMC6819752](/pmc/articles/PMC6819752/)\] \[[PubMed: 31687609](https://pubmed.ncbi.nlm.nih.gov/31687609)\] 4. Luks AM. Can patients with pulmonary hypertension travel to high altitude? High Alt Med Biol. 2009 Fall;10(3):215-9. \[[PubMed: 19775210](https://pubmed.ncbi.nlm.nih.gov/19775210)\] 5. Hakim TS, Michel RP, Minami H, Chang HK. Site of pulmonary hypoxic vasoconstriction studied with arterial and venous occlusion. J Appl Physiol Respir Environ Exerc Physiol. 1983 May;54(5):1298-302. \[[PubMed: 6863090](https://pubmed.ncbi.nlm.nih.gov/6863090)\] 6. León-Velarde F, Ramos MA, Hernández JA, De Idiáquez D, Muñoz LS, Gaffo A, Córdova S, Durand D, Monge C. The role of menopause in the development of chronic mountain sickness. Am J Physiol. 1997 Jan;272(1 Pt 2):R90-4. \[[PubMed: 9038995](https://pubmed.ncbi.nlm.nih.gov/9038995)\] 7. Dempsey JA, Morgan BJ. Humans In Hypoxia: A Conspiracy Of Maladaptation?! Physiology (Bethesda). 2015 Jul;30(4):304-16. \[[PMC free article: PMC4491526](/pmc/articles/PMC4491526/)\] \[[PubMed: 26136544](https://pubmed.ncbi.nlm.nih.gov/26136544)\] 8. Luks AM, Levett D, Martin DS, Goss CH, Mitchell K, Fernandez BO, Feelisch M, Grocott MP, Swenson ER., Caudwell Xtreme Everest Investigators. Changes in acute pulmonary vascular responsiveness to hypoxia during a progressive ascent to high altitude (5300 m). Exp Physiol. 2017 Jun 01;102(6):711-724. \[[PubMed: 28390080](https://pubmed.ncbi.nlm.nih.gov/28390080)\] 9. Robinson JC, Abbott C, Meadows CA, Roach RC, Honigman B, Bull TM. Long-Term Health Outcomes in High-Altitude Pulmonary Hypertension. High Alt Med Biol. 2017 Mar;18(1):61-66. \[[PMC free article: PMC5361756](/pmc/articles/PMC5361756/)\] \[[PubMed: 28061144](https://pubmed.ncbi.nlm.nih.gov/28061144)\] 10. Klinger JR, Abman SH, Gladwin MT. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013 Sep 15;188(6):639-46. \[[PubMed: 23822809](https://pubmed.ncbi.nlm.nih.gov/23822809)\] 11. Sime F, Peñaloza D, Ruiz L. Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level. Br Heart J. 1971 Sep;33(5):647-57. \[[PMC free article: PMC487232](/pmc/articles/PMC487232/)\] \[[PubMed: 5115010](https://pubmed.ncbi.nlm.nih.gov/5115010)\] 12. Xu Y, Liu Y, Liu J, Qian G. Meta-analysis of clinical efficacy of sildenafil, a phosphodiesterase type-5 inhibitor on high altitude hypoxia and its complications. High Alt Med Biol. 2014 Apr;15(1):46-51. \[[PubMed: 24673534](https://pubmed.ncbi.nlm.nih.gov/24673534)\] 13. Taimeh Z. Assessment and treatment of the failing right heart: considerations for transplantation referral. J Thorac Dis. 2019 Sep;11(Suppl 14):S1817-S1820. \[[PMC free article: PMC6783729](/pmc/articles/PMC6783729/)\] \[[PubMed: 31632759](https://pubmed.ncbi.nlm.nih.gov/31632759)\] **Disclosure:** Nicolas Ulloa declares no relevant financial relationships with ineligible companies. **Disclosure:** Jessica Cook declares no relevant financial relationships with ineligible companies.